Machine learning for survival outcome in head and neck squamous cell carcinoma: a multicenter validation study.
Source check: Source checked. Not independent scientific confirmation.
Finding: A voting model trained on SEER records predicted overall survival for head and neck squamous cell carcinoma and was evaluated in German and Swedish cohorts. Its discrimination varied across cohorts; the study supports prognostic assessment, not evidence of treatment benefit.
Technology: Machine-learning survival models use clinicopathological and treatment-related variables, trained on SEER data and assessed in multicenter registry cohorts.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Machine-learning survival models use clinicopathological and treatment-related variables, trained on SEER data and assessed in multicenter registry cohorts.
- Test and result
- The study reports retrospective overall-survival prediction using a large SEER training set and validation cohorts in Germany and Sweden; prognostic performance does not establish treatment benefit.
- Limitation / still unknown
- Validation cohorts support retrospective survival prediction; the study does not test whether model-guided treatment changes survival or clinical decisions.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://doi.org/10.1038/s41598-025-29295-6 · https://europepmc.org/article/MED/41318646
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.